中文简体
中文简体
English
HOME
ABOUT US
Company Profile
Company Culture
Company Honor
R&D
Technology Platform
Pipelines
NEWS
Press Release
Awards
CAREERS
CONTACT US
中文简体
中文简体
English
Search
/uploads/image/img/banner-txt-en-03.svg
首页
-
NEWS
-
Press Release
Press Release
Awards
Press Release
Awards
Beihai Biotech announced that its innovative cancer drug, BH009 (marketed as BEIZRAY), has received approval from the U.S. Food and Drug Administration (FDA)
2024-10-31
U.S. FDA Formally Accepts Beihai Biotech's New Drug Application for Innovative Oncology Drug BH009 (BEIZRAY™)
2024-01-04
Beihai Biotech Founder Dr. Sun Invited to Keynote 'Wisdom in China' Summit at Renmin University Business School
2023-12-26
Beihai Biotech Successfully Concludes Series C Funding, Expediting BH009 Commercialization and Advancing Clinical Trials for Innovative Drug Candidates
2023-12-19
Beihai Biotech Secures “Drug Manufacturing Certificate”
2023-06-15
Landmark Clinical Research Findings of Beihai Biotech's BH009 Unveiled at ASCO 2023
2023-06-12
贝海生物用于治疗晚期三阴性乳腺癌的创新药物BH009获批开展II期临床试验
2023-04-10
贝海生物BH009新药项目在晚期头颈部鳞癌和卵巢癌患者中的I期临床试验完成首例患者给药
2023-03-09
<<
1
2
3
4
>>
